Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
Summary
The 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
Description
The 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source